News

LISAvienna News

LISAvienna: October newsletter highlights recent milestones

Today, we focus on OpGen subsidiary Ares Genetics, AOP Orphan, ImageBiopsy Lab, Valneva, Aposcience, Apeiron Biologics,…

OpGen Subsidiary Ares Genetics Launches AREScloud

- AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolates

-…

LISAvienna News

LISAvienna: Vienna is Austria’s #1 life science hub

The new Vienna Life Science Report 2021/22 confirms that Vienna is Austria’s leading city for biotech, pharma, medical…

Für mehr Versorgungssicherheit: AOP Orphan nimmt Verpackungsanlage in Wien in Betrieb

Sieben Medikamente verpackt AOP Orphan ab 2022 am Standort Wien selbst. Damit steigt die Versorgungssicherheit bei…

UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab

· ImageBiopsy Lab will further develop and launch an AI-based fracture identification tool based on UCB-developed…

LBG OIS Center ist Teil des neuen EU-Forschungsprojekt "Screen4Care"

Genetisches Neugeborenen-Screening und künstliche Intelligenz (KI) sollen Diagnose bei PatientInnen mit selten…

Valneva reports positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001

- VLA2001 successfully met both co-primary endpoints

Superior neutralizing antibody titer levels compared to active…

APOSCIENCE AG completes secretome-based Phase I trial in diabetic foot ulcer (DFU) - DSMB recommends initiation of multinational Phase II trial of MARSYAS II

AposecTM (APO-2) is a secretome-based investigational medicinal product (IMP) derived from stressed peripheral blood…

Sandoz: Was es für die Zukunft braucht: Rahmenbedingungen für die Sicherung des Generika- und Biosimilar-Produktionsstandorts Österreich

Sandoz Österreich gibt seit einem Dreivierteljahrhundert richtungsweisende Impulse für Antibiotika und Biopharmazeutika.

AIT is a member of the Austrian Platform for Human Biomonitoring

New EU projects open up for the Center for Health & Bioresources

LISAvienna News

Fotos LISAvienna Regulatory Konferenz 2021

Hier finden Sie einige Impressionen von der Veranstaltung.

LISAvienna News

Vortragsunterlagen LISAvienna Regulatory Konferenz für Medizinprodukte und In-vitro Diagnostika 2021

Knapp 400 Personen aus dem DACH-Raum interessierten sich für den Austausch über MDR und IVDR am 12. Oktober 2021. Hier…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.